BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BBO-11818 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BBO-11818\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06917079-2384@assetmemo.bio
DTSTAMP:20261121T005701Z
DTSTART;VALUE=DATE:20270831
DTEND;VALUE=DATE:20270901
SUMMARY:BBO-11818: Phase 1 readout est. (NCT06917079)
DESCRIPTION:BBO-11818\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: BBO-1
 1818 in Adult Subjects With KRAS Mutant Cancer\nEstimated primary completi
 on: August 2027. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bbo-
 11818#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06917079
URL:https://assetmemo.bio/drug/bbo-11818#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
